Stock Analysis on Net

AmerisourceBergen Corp. (NYSE:ABC)

$22.49

This company has been moved to the archive! The financial data has not been updated since August 2, 2023.

Financial Reporting Quality: Aggregate Accruals

Microsoft Excel

Earnings can be decomposed into cash and accrual components. The accrual component (aggregate accruals) has been found to have less persistence than the cash component, and therefore (1) earnings with higher accrual component are less persistent than earnings with smaller accrual component, all else equal; and (2) the cash component of earnings should receive a higher weighting evaluating company performance.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Balance-Sheet-Based Accruals Ratio

AmerisourceBergen Corp., balance sheet computation of aggregate accruals

US$ in thousands

Microsoft Excel
Sep 30, 2022 Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017
Operating Assets
Total assets
Less: Cash and cash equivalents
Operating assets
Operating Liabilities
Total liabilities
Less: Short-term debt
Less: Long-term debt, net of current portion
Operating liabilities
 
Net operating assets1
Balance-sheet-based aggregate accruals2
Financial Ratio
Balance-sheet-based accruals ratio3
Benchmarks
Balance-Sheet-Based Accruals Ratio, Competitors4
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.
Balance-Sheet-Based Accruals Ratio, Sector
Health Care Equipment & Services
Balance-Sheet-Based Accruals Ratio, Industry
Health Care

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).

1 2022 Calculation
Net operating assets = Operating assets – Operating liabilities
= =

2 2022 Calculation
Balance-sheet-based aggregate accruals = Net operating assets2022 – Net operating assets2021
= =

3 2022 Calculation
Balance-sheet-based accruals ratio = 100 × Balance-sheet-based aggregate accruals ÷ Avg. net operating assets
= 100 × ÷ [( + ) ÷ 2] =

4 Click competitor name to see calculations.


Net Operating Assets
The net operating assets exhibit significant volatility over the analyzed periods. Initially, there is a decline from approximately 4.87 billion US dollars in 2018 to about 3.79 billion US dollars in 2019. This is followed by a sharp negative value in 2020, indicating a deficit of roughly 1.32 billion US dollars. The figure recovers in 2021, reaching around 4.72 billion US dollars, but then declines again in 2022 to approximately 2.39 billion US dollars. This pattern suggests considerable fluctuations in the company's net operating asset base, potentially reflecting changes in operational efficiency or asset management during these years.
Balance-sheet-based Aggregate Accruals
The balance-sheet-based aggregate accruals show a similarly volatile trend with substantial changes in magnitude and direction. There is a large positive accrual amounting to approximately 1.80 billion US dollars in 2018, which turns negative in both 2019 and 2020 with values near -1.08 billion and -5.11 billion US dollars, respectively. The accruals swing back to a positive figure close to 6.04 billion US dollars in 2021, followed by another negative value of about -2.34 billion US dollars in 2022. These shifts imply significant fluctuations in the timing of revenue and expense recognition, which could affect earnings quality and predictability.
Balance-sheet-based Accruals Ratio
The accruals ratio demonstrates extreme variability, indicating substantial inconsistency in the proportion of accruals relative to net operating assets. The ratio starts at a high positive level of approximately 45.25% in 2018, moves into negative territory at -24.84% in 2019, and then shows an exceptionally large negative figure of -413.07% in 2020. In 2021, the ratio spikes dramatically to about 354.89%, before dropping again to -65.72% in 2022. These extreme fluctuations are indicative of potentially aggressive or highly irregular accrual accounting practices, which may impact the reliability and quality of annual financial reporting.

Cash-Flow-Statement-Based Accruals Ratio

AmerisourceBergen Corp., cash flow statement computation of aggregate accruals

US$ in thousands

Microsoft Excel
Sep 30, 2022 Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017
Net income (loss) attributable to AmerisourceBergen Corporation
Less: Net cash provided by operating activities
Less: Net cash used in investing activities
Cash-flow-statement-based aggregate accruals
Financial Ratio
Cash-flow-statement-based accruals ratio1
Benchmarks
Cash-Flow-Statement-Based Accruals Ratio, Competitors2
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.
Cash-Flow-Statement-Based Accruals Ratio, Sector
Health Care Equipment & Services
Cash-Flow-Statement-Based Accruals Ratio, Industry
Health Care

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).

1 2022 Calculation
Cash-flow-statement-based accruals ratio = 100 × Cash-flow-statement-based aggregate accruals ÷ Avg. net operating assets
= 100 × ÷ [( + ) ÷ 2] =

2 Click competitor name to see calculations.


The analysis of the annual financial reporting quality measures reveals significant fluctuations and shifts over the observed periods.

Net Operating Assets
The net operating assets exhibit considerable volatility across the years. Starting from a positive value of approximately 4.87 billion US dollars in 2018, there is a marked decline to about 3.79 billion in 2019. The trend reverses dramatically in 2020 with a negative figure nearing -1.32 billion, indicating potential operational or asset-related challenges during that year. Subsequently, the net operating assets recover strongly in 2021 to around 4.72 billion but decline again to approximately 2.39 billion in 2022. This pattern suggests instability in the company's operating asset base, possibly reflecting changes in asset management or operating conditions.
Cash-Flow-Statement-Based Aggregate Accruals
The aggregate accruals based on the cash flow statement show notable oscillations with sizable amounts involved. In 2018, accruals are positive at about 1.36 billion US dollars, switching to a negative value close to -1.11 billion in 2019, and plunging further to nearly -5.24 billion in 2020. The year 2021 again sees a reversal to a substantial positive accrual of approximately 5.01 billion, followed by a decrease to a negative accrual near -0.64 billion in 2022. Such volatility might indicate variations in the company's earnings quality and the timing of cash flows relative to reported earnings.
Cash-Flow-Statement-Based Accruals Ratio
The accruals ratio, expressed in percentage terms, accentuates the dramatic shifts observed in aggregate accruals. Beginning at 34.21% in 2018, the ratio turns negative to approximately -25.7% in 2019, before descending sharply to -423.27% in 2020, which suggests significant discrepancies between accruals and cash flow components during that year. The ratio then swings to a high positive level of 294.71% in 2021, reflecting a substantial reversal, and ends at roughly -17.89% in 2022. These wide fluctuations in the accruals ratio may be indicative of irregularities or significant changes in the accrual components in relation to cash flows, impacting the reliability of reported earnings.

Overall, the financial quality measures illustrate a pattern of high variability and abrupt changes, reflecting potentially inconsistent earnings quality and challenges in asset management over the analyzed timeframe.